AbbVie Inc. Share-based Payment Arrangement, Expense, Tax Benefit
AbbVie Inc. (ABBV) reported Share-based Payment Arrangement, Expense, Tax Benefit of $29.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-08-03
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2026-06-30 was $29.00M, a 14.71% decline year-over-year.
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $75.00M, a 7.14% increase year-over-year.
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $31.00M, a 3.13% decline year-over-year.
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $35.00M, a 6.06% increase year-over-year.
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $170.00M, a 6.92% increase from fiscal 2024.
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $159.00M, a 16.91% increase from fiscal 2023.
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $136.00M, a 11.48% increase from fiscal 2022.
- AbbVie Inc. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $122.00M, a 3.17% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.00M 10-Q · filed 2026-08-03 | $104.00M 10-Q · filed 2026-08-03 | $135.00M derived: sum of 3 quarters · filed 2026-08-03 | $170.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $75.00M 10-Q · filed 2026-05-08 | $106.00M derived: sum of 2 quarters · filed 2026-05-08 | $141.00M derived: sum of 3 quarters · filed 2026-05-08 | $175.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $66.00M derived: sum of 2 quarters · filed 2026-02-20 | $100.00M derived: sum of 3 quarters · filed 2026-08-03 | $170.00M 10-K · filed 2026-02-20 |
| 2025-09-30 | $35.00M 10-Q · filed 2025-11-04 | $69.00M derived: sum of 2 quarters · filed 2026-08-03 | $139.00M 10-Q · filed 2025-11-04 | $171.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $34.00M 10-Q · filed 2026-08-03 | $104.00M 10-Q · filed 2026-08-03 | $136.00M derived: sum of 3 quarters · filed 2026-08-03 | $169.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $70.00M 10-Q · filed 2026-05-08 | $102.00M derived: sum of 2 quarters · filed 2026-05-08 | $135.00M derived: sum of 3 quarters · filed 2026-05-08 | $169.00M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $65.00M derived: sum of 2 quarters · filed 2026-02-20 | $99.00M derived: sum of 3 quarters · filed 2026-02-20 | $159.00M 10-K · filed 2026-02-20 |
| 2024-09-30 | $33.00M 10-Q · filed 2025-11-04 | $67.00M derived: sum of 2 quarters · filed 2025-11-04 | $127.00M 10-Q · filed 2025-11-04 | $152.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $34.00M 10-Q · filed 2025-08-04 | $94.00M 10-Q · filed 2025-08-04 | $119.00M derived: sum of 3 quarters · filed 2026-02-20 | $145.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $60.00M 10-Q · filed 2025-05-09 | $85.00M derived: sum of 2 quarters · filed 2026-02-20 | $111.00M derived: sum of 3 quarters · filed 2026-02-20 | $141.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $51.00M derived: sum of 2 quarters · filed 2026-02-20 | $81.00M derived: sum of 3 quarters · filed 2026-02-20 | $136.00M 10-K · filed 2026-02-20 |
| 2023-09-30 | $26.00M 10-Q · filed 2024-11-04 | $56.00M derived: sum of 2 quarters · filed 2024-11-04 | $111.00M 10-Q · filed 2024-11-04 | $131.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $30.00M 10-Q · filed 2024-08-07 | $85.00M 10-Q · filed 2024-08-07 | $105.00M derived: sum of 3 quarters · filed 2025-02-14 | $130.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $55.00M 10-Q · filed 2024-05-03 | $75.00M derived: sum of 2 quarters · filed 2025-02-14 | $100.00M derived: sum of 3 quarters · filed 2025-02-14 | $121.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $45.00M derived: sum of 2 quarters · filed 2025-02-14 | $66.00M derived: sum of 3 quarters · filed 2025-02-14 | $122.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $25.00M 10-Q · filed 2023-11-06 | $46.00M derived: sum of 2 quarters · filed 2023-11-06 | $102.00M 10-Q · filed 2023-11-06 | $127.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $21.00M 10-Q · filed 2023-08-07 | $77.00M 10-Q · filed 2023-08-07 | $102.00M derived: sum of 3 quarters · filed 2024-02-20 | $129.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $56.00M 10-Q · filed 2023-05-05 | $81.00M derived: sum of 2 quarters · filed 2024-02-20 | $108.00M derived: sum of 3 quarters · filed 2024-02-20 | $134.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $52.00M derived: sum of 2 quarters · filed 2024-02-20 | $78.00M derived: sum of 3 quarters · filed 2024-02-20 | $126.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $27.00M 10-Q · filed 2022-11-04 | $53.00M derived: sum of 2 quarters · filed 2022-11-04 | $101.00M 10-Q · filed 2022-11-04 | $123.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $26.00M 10-Q · filed 2022-08-04 | $74.00M 10-Q · filed 2022-08-04 | $96.00M derived: sum of 3 quarters · filed 2023-02-17 | $128.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $48.00M 10-Q · filed 2022-05-06 | $70.00M derived: sum of 2 quarters · filed 2023-02-17 | $102.00M derived: sum of 3 quarters · filed 2023-02-17 | $140.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $54.00M derived: sum of 2 quarters · filed 2023-02-17 | $92.00M derived: sum of 3 quarters · filed 2023-02-17 | $131.00M 10-K · filed 2023-02-17 |
| 2020-09-30 | $32.00M 10-Q · filed 2021-11-02 | $70.00M derived: sum of 2 quarters · filed 2021-11-02 | $109.00M 10-Q · filed 2021-11-02 | $125.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $38.00M 10-Q · filed 2021-08-02 | $77.00M 10-Q · filed 2021-08-02 | $93.00M derived: sum of 3 quarters · filed 2022-02-18 | $108.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $39.00M 10-Q · filed 2021-05-07 | $55.00M derived: sum of 2 quarters · filed 2022-02-18 | $70.00M derived: sum of 3 quarters · filed 2022-02-18 | $86.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $31.00M derived: sum of 2 quarters · filed 2022-02-18 | $47.00M derived: sum of 3 quarters · filed 2022-02-18 | $80.00M 10-K · filed 2022-02-18 |
| 2019-09-30 | $15.00M 10-Q · filed 2020-11-04 | $31.00M derived: sum of 2 quarters · filed 2020-11-04 | $64.00M 10-Q · filed 2020-11-04 | $76.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $16.00M 10-Q · filed 2020-08-04 | $49.00M 10-Q · filed 2020-08-04 | $61.00M derived: sum of 3 quarters · filed 2021-02-19 | $74.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $33.00M 10-Q · filed 2020-05-08 | $45.00M derived: sum of 2 quarters · filed 2021-02-19 | $58.00M derived: sum of 3 quarters · filed 2021-02-19 | $77.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $25.00M derived: sum of 2 quarters · filed 2021-02-19 | $44.00M derived: sum of 3 quarters · filed 2021-02-19 | $73.00M 10-K · filed 2021-02-19 |
| 2018-09-30 | $13.00M 10-Q · filed 2019-11-06 | $32.00M derived: sum of 2 quarters · filed 2019-11-06 | $61.00M 10-Q · filed 2019-11-06 | $49.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $19.00M 10-Q · filed 2019-08-05 | $48.00M 10-Q · filed 2019-08-05 | $36.00M derived: sum of 3 quarters · filed 2020-02-21 | $56.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $29.00M 10-Q · filed 2019-05-03 | $17.00M derived: sum of 2 quarters · filed 2020-02-21 | $37.00M derived: sum of 3 quarters · filed 2020-02-21 | $55.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $8.00M derived: sum of 2 quarters · filed 2020-02-21 | $26.00M derived: sum of 3 quarters · filed 2020-02-21 | $73.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | $20.00M 10-Q · filed 2018-11-07 | $38.00M derived: sum of 2 quarters · filed 2018-11-07 | $85.00M 10-Q · filed 2018-11-07 | $106.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $18.00M 10-Q · filed 2018-08-07 | $65.00M 10-Q · filed 2018-08-07 | $86.00M derived: sum of 3 quarters · filed 2019-02-27 | $99.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $47.00M 10-Q · filed 2018-05-04 | $68.00M derived: sum of 2 quarters · filed 2019-02-27 | $81.00M derived: sum of 3 quarters · filed 2019-02-27 | $123.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $34.00M derived: sum of 2 quarters · filed 2019-02-27 | $76.00M derived: sum of 3 quarters · filed 2019-02-27 | $104.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $13.00M 10-Q · filed 2017-11-07 | $55.00M derived: sum of 2 quarters · filed 2017-11-07 | $83.00M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $42.00M 10-Q · filed 2017-08-07 | $89.00M 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $48.00M 10-Q · filed 2017-05-05 | |||
| 2015-12-31 | $89.00M 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $73.00M 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $68.00M 10-K · filed 2016-02-19 | |||
| 2012-12-31 | $56.00M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | $48.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |